Trial · NCT00559585
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double Blind ST Period Main Study | STARTED | Subcutaneous (SC) Abatacept | 736 | |
| Double Blind ST Period Main Study | STARTED | Intravenous (IV) Abatacept | 721 | |
| Double Blind ST Period Main Study | COMPLETED | Subcutaneous (SC) Abatacept | 693 | |
| Double Blind ST Period Main Study | COMPLETED | Intravenous (IV) Abatacept | 676 | |
| Double Blind ST Period Main Study | NOT COMPLETED | Subcutaneous (SC) Abatacept | 43 | |
| Double Blind ST Period Main Study | NOT COMPLETED | Intravenous (IV) Abatacept | 45 | |
| Anti-TNF Sub-Study in ST Period | STARTED | Subcutaneous (SC) Abatacept | 8 | |
| Anti-TNF Sub-Study in ST Period | STARTED | Intravenous (IV) Abatacept | 10 | |
| Anti-TNF Sub-Study in ST Period | COMPLETED | Subcutaneous (SC) Abatacept | 7 | |
| Anti-TNF Sub-Study in ST Period | COMPLETED | Intravenous (IV) Abatacept | 9 | |
| Anti-TNF Sub-Study in ST Period | NOT COMPLETED | Subcutaneous (SC) Abatacept | 1 | |
| Anti-TNF Sub-Study in ST Period | NOT COMPLETED | Intravenous (IV) Abatacept | 1 | |
| Open Label LT Period Main + Sub-Study | STARTED | Subcutaneous (SC) Abatacept | 1,373 | |
| Open Label LT Period Main + Sub-Study | STARTED | Intravenous (IV) Abatacept | 0 | |
| Open Label LT Period Main + Sub-Study | COMPLETED | Subcutaneous (SC) Abatacept | 945 | |
| Open Label LT Period Main + Sub-Study | COMPLETED | Intravenous (IV) Abatacept | 0 | |
| Open Label LT Period Main + Sub-Study | NOT COMPLETED | Subcutaneous (SC) Abatacept | 428 | |
| Open Label LT Period Main + Sub-Study | NOT COMPLETED | Intravenous (IV) Abatacept | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00559585/flow